Larvol Delta - Immunai-and-Baylor-College-of-Medicine-Provide-Updated-Interim-Phase-1-Results-for-antiGD2-CAR-NKTCell-Therapy-in-RelapsedRefractory-Neuroblastoma

KUR-501 - Athenex

https://www.businesswire.com/news/home/20230515005607/en/Immunai-and-Baylor-College-of-Medicine-Provide-Updated-Interim-Phase-1-Results-for-anti-GD2-CAR-NKT-Cell-Therapy-in-RelapsedRefractory-Neuroblastoma

May 15, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next